CD4+ and CD8+ T cell-dependent antiviral immunity requires STIM1 and STIM2

Journal of Clinical Investigation

Volumn 124, Issue 10, 2014, Pages 4549-4563

  Shaw, Patrick J ^a   Weidinger, Carl ^a   Vaeth, Martin ^a   Luethy, Kevin ^a,c   Kaech, Susan M ^b   Feske, Stefan ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

STROMAL INTERACTION MOLECULE 1; STROMAL INTERACTION MOLECULE 2; CALCIUM CHANNEL; CD40 LIGAND; CELL ADHESION MOLECULE; MEMBRANE PROTEIN; STIM1 PROTEIN, HUMAN; STIM1 PROTEIN, MOUSE; STIM2 PROTEIN, HUMAN; STIM2 PROTEIN, MOUSE; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; SECONDARY INFECTION; VIRUS IMMUNITY; VIRUS INFECTION; ANIMAL; ARENAVIRUS INFECTION; BONE MARROW CELL; CALCIUM SIGNALING; CYTOLOGY; GENETICS; HOMOZYGOTE; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; METABOLISM; VIROLOGY;

ANIMALS; ARENAVIRIDAE INFECTIONS; BONE MARROW CELLS; CALCIUM CHANNELS; CALCIUM SIGNALING; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; HOMOZYGOTE; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; NEOPLASM PROTEINS;

EID: 84907484551     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI76602     Document Type: Article

References (83)

1. Feske S. Calcium signalling in lymphocyte activation and disease. Nat Rev Immunol. 2007;7(9):690-702.
2. Hogan PG, Lewis RS, Rao A. Molecular basis of calcium signaling in lymphocytes: STIM and ORAI. Annu Rev Immunol. 2010;28:491-533.
3. Feske S, Skolnik EY, Prakriya M. Ion channels and transporters in lymphocyte function and immunity. Nat Rev Immunol. 2012;12(7):532-547.
4. Lewis RS. Calcium signaling mechanisms in T lymphocytes. Annu Rev Immunol. 2001;19:497-521.
5. Macian F. NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol. 2005;5(6):472-484.
6. 2+ influx. Curr Biol. 2005;15(13):1235-1241.
7. 2+ channel function. J Cell Biol. 2005;169(3):435-445.
8. Feske S, et al. A mutation in Orai1 causes immune deficiency by abrogating CRAC channel function. Nature. 2006;441(7090):179-185.
9. 2+ entry. Science. 2006;312(5777):1220-1223.
10. Zhang SL, et al. Genome-wide RNAi screen of Ca (2+) influx identifies genes that regulate Ca (2+) release-activated Ca (2+) channel activity. Proc Natl Acad Sci U S A. 2006;103(24):9357-9362.
11. Cahalan MD. STIMulating store-operated Ca (2+) entry. Nat Cell Biol. 2009;11(6):669-677.
12. Shaw PJ, Feske S. Physiological and pathophysiological functions of SOCE in the immune system. Front Biosci (Elite Ed). 2012;4:2253-2268.
13. Fuchs S, et al. Antiviral and regulatory T cell immunity in a patient with stromal interaction molecule 1 deficiency. J Immunol. 2012;188(3):1523-1533.
14. 2+ entry cause immunodeficiency, myopathy, and ectodermal dysplasia. J Allergy Clin Immunol. 2009;124(6):1311-1318.e7.
15. Picard C, et al. STIM1 mutation associated with a syndrome of immunodeficiency and autoimmunity. N Engl J Med. 2009;360(19):1971-1980.
16. Byun M, et al. Whole-exome sequencing-based discovery of STIM1 deficiency in a child with fatal classic Kaposi sarcoma. J Exp Med. 2010;207(11):2307-2312.
17. Sahin G, et al. Classic Kaposi sarcoma in 3 unrelated Turkish children born to consanguineous kindreds. Pediatrics. 2010;125(3):e704-e708.
18. Feske S, Giltnane J, Dolmetsch R, Staudt LM, Rao A. Gene regulation mediated by calcium signals in T lymphocytes. Nat Immunol. 2001;2(4):316-324.
19. Feske S, et al. Severe combined immunodeficiency due to defective binding of the nuclear factor of activated T cells in T lymphocytes of two male siblings. Eur J Immunol. 1996;26(9):2119-2126.
20. Ma J, McCarl CA, Khalil S, Luthy K, Feske S. T-cell-specific deletion of STIM1 and STIM2 protects mice from EAE by impairing the effector functions of Th1 and Th17 cells. Eur J Immunol. 2010;40(11):3028-3042.
21. Oh-Hora M, et al. Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance. Nat Immunol. 2008;9(4):432-443.
22. Beyersdorf N, et al. STIM1-independent T cell development and effector function in vivo. J Immunol. 2009;182(6):3390-3397.
23. Weidinger C, Shaw PJ, Feske S. STIM1 and STIM2-mediated Ca (2+) influx regulates antitumour immunity by CD8 (+) T cells. EMBO Mol Med. 2013;5(9):1311-1321.
24. Schuhmann MK, et al. Stromal interaction molecules 1 and 2 are key regulators of autoreactive T cell activation in murine autoimmune central nervous system inflammation. J Immunol. 2010;184(3):1536-1542.
25. 2+ entry through ORAI1 is critical for T cell-mediated autoimmunity and allograft rejection. J Immunol. 2010;185(10):5845-5858.
26. Kaech SM, Cui W. Transcriptional control of effector and memory CD8 (+) T cell differentiation. Nat Rev Immunol. 2012;12(11):749-761.
27. Zehn D, King C, Bevan MJ, Palmer E. TCR signaling requirements for activating T cells and for generating memory. Cell Mol Life Sci. 2012;69(10):1565-1575.
28. Teixeiro E, et al. Different T cell receptor signals determine CD8+ memory versus effector development. Science. 2009;323(5913):502-505.
29. Swain SL, McKinstry KK, Strutt TM. Expanding roles for CD4 T cells in immunity to viruses. Nat Rev Immunol. 2012;12(2):136-148.
30. Thomsen AR, Nansen A, Christensen JP, Andreasen SO, Marker O. CD40 ligand is pivotal to efficient control of virus replication in mice infected with lymphocytic choriomeningitis virus. J Immunol. 1998;161(9):4583-4590.
31. 2+ T cells. Immunity. 2011;35(5):792-805.
32. Bachmann MF, Hunziker L, Zinkernagel RM, Storni T, Kopf M. Maintenance of memory CTL responses by T helper cells and CD40-CD40 ligand: antibodies provide the key. Eur J Immunol. 2004;34(2):317-326.
33. Lefrancois L, Obar JJ. Once a killer, always a killer: from cytotoxic T cell to memory cell. Immunol Rev. 2010;235(1):206-218.
34. Arens R, Schoenberger SP. Plasticity in programming of effector and memory CD8 T-cell formation. Immunol Rev. 2010;235(1):190-205.
35. Cui W, Kaech SM. Generation of effector CD8+ T cells and their conversion to memory T cells. Immunol Rev. 2010;236:151-166.
36. Feau S, Arens R, Togher S, Schoenberger SP. Autocrine IL-2 is required for secondary population expansion of CD8 (+) memory T cells. Nat Immunol. 2011;12(9):908-913.
37. 2+ memory T cells. Nature. 2006;441(7095):890-893.
38. Eberlein J, Davenport B, Nguyen TT, Victorino F, Sparwasser T, Homann D. Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity. J Virol. 2012;86(4):1955-1970.
39. + T cells are restricted by the up-regulation of PD-1. J Immunol. 2009;182(7):4244-4254.
40. Khanolkar A, Fuller MJ, Zajac AJ. T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus. Immunol Res. 2002;26(1-3):309-321.
41. 2+ T cell response during acute LCMV infection. Adv Exp Med Biol. 1998;452:111-122.
42. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, Ahmed R. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol. 2003;4(12):1191-1198.
43. 2+ memory T cell subsets. Proc Natl Acad Sci U S A. 2004;101(15):5610-5615.
44. Pores-Fernando AT, Zweifach A. Calcium influx and signaling in cytotoxic T-lymphocyte lytic granule exocytosis. Immunol Rev. 2009;231(1):160-173.
45. 2+ T cells to compete for the memory cell niche. J Immunol. 2010;185(9):4988-4992.
46. Joshi NS, et al. Inflammation directs memory precursor and short-lived effector CD8 (+) T cell fates via the graded expression of T-bet transcription factor. Immunity. 2007;27(2):281-295.
47. 2+ T cell fate coupled by T-bet and eomesodermin. Nat Immunol. 2005;6(12):1236-1244.
48. Schluns KS, Lefrancois L. Cytokine control of memory T-cell development and survival. Nat Rev Immunol. 2003;3(4):269-279.
49. Schluns KS, Williams K, Ma A, Zheng XX, Lefrancois L. Cutting edge: requirement for IL-15 in the generation of primary and memory antigen-specific CD8 T cells. J Immunol. 2002;168(10):4827-4831.
50. Schluns KS, Kieper WC, Jameson SC, Lefrancois L. Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol. 2000;1(5):426-432.
51. Jin HT, et al. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci U S A. 2010;107(33):14733-14738.
52. Wherry EJ. T cell exhaustion. Nat Immunol. 2011;12(6):492-499.
53. Wherry EJ, Blattman JN, Murali-Krishna K, Van der Most R, Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol. 2003;77(8):4911-4927.
54. Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science. 2003;300(5617):337-339.
55. Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science. 2003;300(5617):339-342.
56. 2+ T lymphocytes. Nature. 2003;421(6925):852-856.
57. + T cells and is quickly expressed on the cell surface in an antigen-specific manner. Blood. 2007;110(7):2520-2527.
58. Sarawar SR, Lee BJ, Reiter SK, Schoenberger SP. Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpes virus. Proc Natl Acad Sci U S A. 2001;98(11):6325-6329.
59. Demangel C, Palendira U, Feng CG, Heath AW, Bean AG, Britton WJ. Stimulation of dendritic cells via CD40 enhances immune responses to Mycobacterium tuberculosis infection. Infection and immunity. 2001;69(4):2456-2461.
60. Rolph MS, Kaufmann SH. CD40 signaling converts a minimally immunogenic antigen into a potent vaccine against the intracellular pathogen Listeria monocytogenes. J Immunol. 2001;166(8):5115-5121.
61. 2+ cell responses. J Immunol. 2003;170(5):2727-2733.
62. Hermans IF, Ritchie DS, Daish A, Yang J, Kehry MR, Ronchese F. Impaired ability of MHC class II-/-dendritic cells to provide tumor protection is rescued by CD40 ligation. J Immunol. 1999;163(1):77-81.
63. Bartholdy C, Kauffmann SO, Christensen JP, Thomsen AR. Agonistic anti-CD40 antibody profoundly suppresses the immune response to infection with lymphocytic choriomeningitis virus. J Immunol. 2007;178(3):1662-1670.
64. Maul-Pavicic A, et al. ORAI1-mediated calcium influx is required for human cytotoxic lymphocyte degranulation and target cell lysis. Proc Natl Acad Sci U S A. 2011;108(8):3324-3329.
65. Sullivan BM, Juedes A, Szabo SJ, Von Herrath M, Glimcher LH. Antigen-driven effector CD8 T cell function regulated by T-bet. Proc Natl Acad Sci U S A. 2003;100(26):15818-15823.
66. + T cells after acute infection. Nat Immunol. 2004;5(9):927-933.
67. 2+ effector T cell responses. J Immunol. 2000;164(7):3689-3697.
68. 2+ T cells. J Immunol. 2004;173(4):2217-2221.
69. Sun JC, Bevan MJ. Cutting edge: long-lived CD8 memory and protective immunity in the absence of CD40 expression on CD8 T cells. J Immunol. 2004;172(6):3385-3389.
70. Behrens G, et al. Helper T cells, dendritic cells and CTL Immunity. Immunol Cell Biol. 2004;82(1):84-90.
71. Reis E Sousa C. Dendritic cells in a mature age. Nat Re v Immunol. 2006;6(6):476-483.
72. Lindgren H, Axcrona K, Leanderson T. Regulation of transcriptional activity of the murine CD40 ligand promoter in response to signals through TCR and the costimulatory molecules CD28 and CD2. J Immunol. 2001;166(7):4578-4585.
73. 2+ T cells. J Immunol. 2002;168(10):4936-4945.
74. Brunner M, Zhang M, Genin A, Ho IC, Cron RQ. A T-cell-specific CD154 transcriptional enhancer located just upstream of the promoter. Genes Immun. 2008;9(7):640-649.
75. Koguchi Y, Gardell JL, Thauland TJ, Parker DC. Cyclosporine-resistant, Rab27a-independent mobilization of intracellular preformed CD40 ligand mediates antigen-specific T cell help in vitro. J Immunol. 2011;187(2):626-634.
76. Borrow P, et al. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J Exp Med. 1996;183(5):2129-2142.
77. Feske S. Immunodeficiency due to defects in store-operated calcium entry. Ann N Y Acad Sci. 2011;1238:74-90.
78. Feske S, Draeger R, Peter HH, Eichmann K, Rao A. The duration of nuclear residence of NFAT determines the pattern of cytokine expression in human SCID T cells. J Immunol. 2000;165(1):297-305.
79. Luo C, et al. Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes. Mol Cell Biol. 1996;16(7):3955-3966.
80. Oestreich KJ, Yoon H, Ahmed R, Boss JM. NFATc1 regulates PD-1 expression upon T cell activation. J Immunol. 2008;181(7):4832-4839.
81. 2+ entry in the immune system and beyond. Immunol Rev. 2009;231(1):189-209.
82. Von Herrath M, Whitton JL. Animal models using lymphocytic choriomeningitis virus. Curr Protoc Immunol. 2001; Chapter 19:Unit 19.
83. Boettler T, et al. OX40 facilitates control of a persistent virus infection. PLoS Pathog. 2012;8(9):e1002913.